Original language | English (US) |
---|---|
Pages (from-to) | 900-902 |
Number of pages | 3 |
Journal | Biochemical Pharmacology |
Volume | 34 |
Issue number | 6 |
DOIs | |
State | Published - Mar 15 1985 |
ASJC Scopus subject areas
- Biochemistry
- Pharmacology
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Salicylate-induced loose coupling : protonmotive force measurements. / Haas, Richard; Davies Parker, W.; Stumpf, David et al.
In: Biochemical Pharmacology, Vol. 34, No. 6, 15.03.1985, p. 900-902.Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Salicylate-induced loose coupling
T2 - protonmotive force measurements
AU - Haas, Richard
AU - Davies Parker, W.
AU - Stumpf, David
AU - Eguren, Luigi A.
N1 - Funding Information: Salicylated oess timulateo ligomycins ensitiveA TPasesi n in rat liver mitochondritah rougha n increasein state4 somep reparation\[s5 \]b, ut this is not the explanatiofno r proton conductance\[ 13\].W ith both salicylate and the state4 acceleratiown ith salicylatein rat liver. Our octanoatein creaseds, ubstratec onsumptionw ill result protonmotivef orce measurementssh owed a small along with the acceleratedo xygen consumptiono f a reduction in protonmotivefo rce and transmembrane" looselyc oupled"s tate4 . Both octanoataen d salicylate electricapl otentiailn state3 which was not statistically have effectso n mitochondriaolx idativep hosphorylation significanTt.h isp rotonmotivfoer cew ass ufficientto sustain whichm ayi nduceo r potentiatteh em itochondridala mage phosphorylatioonf ADP to ATP. However, in state 4 occurringin Reye Syndrome. small changesin protonmotivfeo rceand transmembrane In summary,r ecente vidences uggeststh at salicylate electricapl otentiawl erea ssociatewd ith a 2-fold increase ingestionis associatewd ith Reye SyndromeW. e studied in oxygenc onsumptiorna tea nda 4-foldi ncreasien proton the effecto f salicylateo n isolatedr at liver mitochondria, conductanceT.h is suggeststh at in state 4 an increased confirminpgr eviouws orks howinga nu ncouplinegf fecta nd numbero f protonc hannelas re availableI.t follows that investigatintgh e mechanismof this action by use of a increasedo xygen and substratec onsumptionw ill be protonmotivfeo rce assay. Salicylate( 1 mM) produced required to maintain the protonmotivefo rce. These loosec ouplingo f state4 rateso f oxidativep hosphorylation measuremenptrso vided irecte videnceth atthe actiono f allowing preservation of ATP production. The salicylatoe n mitochondraiat this concentratioisn t hato f a protonmotivefo rce and the transmembraneele ctrical protoni onophore. potentiawl erer educedin state4 . Salicylatea ppearedto The increased ADP/O ratios observed in this be acting as a proton ionophorea s shown by a 4-fold polarographsict udyw ith 1 mM salicylatem ayr esultf rom increasein state4 protonc onductance. the 3-min preincubationin which matrix adenine nucleotidesm ay be lost or translocasien hibitionm ay Acknowledgements--Twhoirsk w ass upportebdy a Clinical becomea significanfta ctor. ResearcGh rantf romt heM uscularD ystrophAy ssociation; The inhibitiono f state3 rateso f oxygenc onsumption NIH Program Project Grant HD08315, Center Grant (Table 1) which reacheds ignificancfeo r ol-ketoglutarateH D04024, and National Research Service Award has beeno bservedb efore\ [4,8 \].P ossiblee xplanationasr e HD07096, all from NICHD; Pediatrica nd Adult CRC an inhibitiono f ~-ketoglutaradteeh ydrogenawseh ichw as Grant RR00069 from the General Clinical Research first noted by Kaplan et al. \[12\]o r, alternativelya,n Center'sP rogramo f the Divisiono f ResearchR esources; inhibitorye ffecto n the ATP-ADP translocas\e[9 \]. fundingf rom the Friedreich'As taxiaGroup in America, Octanoatme aya lsob eof significancien the pathogenesis Inc.; and an AcademicS enatere searcshu pporgt rantf rom of Reye'ss yndromaen di nducesa similar" loosec oupling" the Universityo f California,S anDiego.
PY - 1985/3/15
Y1 - 1985/3/15
UR - http://www.scopus.com/inward/record.url?scp=0021952904&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021952904&partnerID=8YFLogxK
U2 - 10.1016/0006-2952(85)90774-9
DO - 10.1016/0006-2952(85)90774-9
M3 - Article
C2 - 3977963
AN - SCOPUS:0021952904
SN - 0006-2952
VL - 34
SP - 900
EP - 902
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 6
ER -